RA Capital Management’s Climb Bio CLYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $63.2M | Hold |
|
|||||
|
2025
Q2 | $39M | Hold |
|
|||||
|
2025
Q1 | $38.3M | Hold |
|
|||||
|
2024
Q4 | $56.6M | Hold |
|
|||||
|
2024
Q3 | $160M | Hold |
|
|||||
|
2024
Q2 | $223M | Buy |
|
|||||
|
2024
Q1 | $36M | Hold |
|
|||||
|
2023
Q4 | $35.5M | Hold |
|
|||||
|
2023
Q3 | $34.6M | Hold |
|
|||||
|
2023
Q2 | $36.8M | Hold |
|
|||||
|
2023
Q1 | $38.1M | Hold |
|
|||||
|
2022
Q4 | $48.3M | Hold |
|
|||||
|
2022
Q3 | $42.5M | Hold |
|
|||||
|
2022
Q2 | $39.7M | Hold |
|
|||||
|
2022
Q1 | $110M | Hold |
|
|||||
|
2021
Q4 | $138M | Hold |
|
|||||
|
2021
Q3 | $236M | Buy |
|